Company intelligence / Profile preview
Wuhan BravoVax Co., Ltd
Wuhan, Hubei, Chinabravovax.com ↗
- Ownership
- Private
- Employees
- ~249
- Development stage
- Other
01
Overview
BravoVax specializes in the R&D, manufacturing, and marketing of high-end human vaccines targeting major infectious diseases. The company has developed or is developing several blockbuster vaccine candidates including for COVID‑19, rotavirus, pneumococcus, HPV, and varicella-zoster. Products are being advanced toward commercialization under Chinese and international regulatory standards.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Recombinant protein vaccinesConjugate vaccinesMultivalent vaccinesViral vector-based vaccines
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Member of Developing Countries Vaccine Manufacturers Network (DCVMN)Council member of China Association for Vaccines (CAV)
Beyond the preview
Go deeper on Wuhan BravoVax Co., Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuhan BravoVax Co., Ltd.